3
Announcements
Trials
Browse
Landscape
Status
Enrolling by invitation
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
66
Rectal Neoplasms
9
Carcinoma, Non-Small-Cell Lung
8
Triple Negative Breast Neoplasms
7
Lung Neoplasms
6
Adenocarcinoma of Lung
6
Carcinoma, Intraductal, Noninfiltrating
5
Breast Carcinoma In Situ
4
Pancreatic Neoplasms
2
Unilateral Breast Neoplasms
1
Transsexualism
1
Solitary Pulmonary Nodule
1
Social Isolation
1
Recurrence
1
Piebaldism
1
Patient Satisfaction
1
Pain, Postoperative
1
Neoplastic Cells, Circulating
1
Neoplasm Micrometastasis
1
Margins of Excision
1
Lymphedema
1
Local Recurrence of Malignant Tumor of Breast
1
Inflammatory Breast Neoplasms
1
Gynecomastia
1
Gastrointestinal Stromal Tumors
1
Chordoma
1
Carcinoma, Lobular
1
Carcinoma, Ductal, Breast
1
Carcinoma, Ductal
1
COVID-19
1
Interventions
Bupivacaine
32
Ropivacaine
19
Saline Solution
17
Dexmedetomidine
17
Morphine
12
Ketamine
11
Sodium Chloride
10
Acetaminophen
10
Lidocaine
9
Pregabalin
7
Control Groups
7
Dexamethasone
5
Gabapentin
4
Epinephrine
4
Anesthetics, Local
4
Analgesia, Patient-Controlled
4
parecoxib
3
oxycodone-acetaminophen
3
Tea
3
Surgical Procedures, Operative
3
Midazolam
3
Ketorolac
3
Injections, Epidural
3
Fentanyl
3
Esketamine
3
Dental Occlusion
3
Anti-Inflammatory Agents, Non-Steroidal
3
Anesthesia, General
3
Analgesics, Opioid
3
Vitamins
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Pain, Postoperative
×
Mastectomy, Segmental
×
Clear all
NCT05876390
2026-04-16
IRACPoP
Niguarda Hospital
Enrolling by invitation
1,500 enrolled